Paul Carlson

Paul Carlson

Company: FDA

Job title: Principal Investigator


Regulatory Considerations for Microbiome-based Therapeutics 9:00 am

• Overview of investigational new drug protocol requirements • CMC considerations for live biotherapeutic products • CMC considerations for fecal transplant based productsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.